India-based healthcare and life sciences technology provider, CitiusTech, claims to have developed the industry's first generative AI quality and trust solution. The CitiusTech Gen AI Quality & Trust solution is designed to aid in the design, development, integration, monitoring, and enhancement of quality and trust in generative AI (genAI) applications within healthcare.
The software employs an automated design and decision-making framework, offering pre-packaged measures, automated output validation, and monitoring across seven dimensions, including Accuracy, Calibration, Robustness, Fairness, Bias, Toxicity, and Efficiency. CitiusTech asserts that their solution fully integrates into existing MLOps, DataOps, and quality management solutions, providing an end-to-end approach to quantitatively measuring, verifying, and monitoring genAI solutions in healthcare.
The significance of this development lies in its potential to address the lack of established, technology-agnostic solutions for measuring the quality and trustworthiness of healthcare genAI solutions. According to CitiusTech, over 80% of genAI proofs of concept and initiatives are delayed due to concerns about reliability, compliance, and trust. The company plans to seamlessly integrate this capability into all its solutions and projects, aiming to instil confidence in clients looking to scale genAI-powered solutions.
The broader trend in the Asia-Pacific region indicates cautious adoption of genAI in healthcare, with concerns about safety and effectiveness slowing down its acceptance, particularly in applications directly impacting patient care. However, notable adoptions, such as China Medical University Hospital in Taiwan leveraging Google Cloud's MedLM for precision cancer treatment tools, and initiatives by health tech agencies like Synapxe in Singapore, demonstrate ongoing efforts to incorporate genAI into healthcare solutions.
Click here to read the original news story.